We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Statin Therapy and Cognitive Deficits Associated With Neurofibromatosis Type 1—Reply

Ype Elgersma, PhD; Lianne C. Krab, MSc; Henriëtte A. Moll, MD, PhD
JAMA. 2008;300(20):2369-2370. doi:10.1001/jama.2008.688.
Text Size: A A A
Published online


In Reply: Dr Jansen raises questions about the rationale of our trial and the value of the NF1 mouse model for translational research.1 It is important to re-emphasize that the NF1 protein is not involved in cholesterol metabolism. NF1 is a negative regulator of RAS activity, and increased RAS signaling has been shown to underlie the learning deficits of Nf1+/– mice.2 The rationale to treat the cognitive deficits with statins was based on 2 fundamental findings in the cancer literature: RAS requires posttranslational isoprenylation for proper signaling, and RAS transforming activity can be suppressed by reducing the synthesis of the isoprenyl groups by statins.1,3,4 The molecular and behavioral deficits of Nf1+/– mice can indeed be ameliorated by decreasing RAS activity, either genetically or by administrating farnesyl transferase inhibitors or statins.1,2


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




November 26, 2008
Jacobus F. A. Jansen, PhD
JAMA. 2008;300(20):2369-2370. doi:10.1001/jama.2008.687.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.